Cancer

Pharmalot Ed Silverman

STAT Plus: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug

Pharma Andrew Joseph

STAT Plus: Novartis picks up experimental breast cancer therapy for $2B

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era

Biotech Angus Chen

STAT Plus: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy

Health Sarah Todd

Smoking rates are at a historic low. You’re not hearing about it from the government

In the Lab Angus Chen

STAT Plus: Cancer cells can ‘barf’ proteins onto their cell surface. That may create new targets for immunotherapies

Hospitals Jessica Bartlett — Boston Globe

STAT Plus: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again

Biotech Andrew Joseph

STAT Plus: BioNTech founders to depart, form new mRNA-focused company

Biotech Andrew Joseph

STAT Plus: Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B

First Opinion Mark J. Ratain and David A. Hyman

CMS shouldn’t be paying for higher-than-necessary doses of cancer drugs

STAT Madness Amanda Erickson

From ALS to dental floss: Here are the teams competing in STAT Madness 2026

Exclusive Adam Feuerstein

STAT Plus: A rare disease drug was approvable, then it wasn’t. Inside a surprise rejection by the FDA

Pharmalot Ed Silverman

STAT Plus: Bayer sues J&J over ‘false and misleading claims’ about competing prostate cancer treatments

Biotech Adam Feuerstein

STAT Plus: Gilead to buy Arcellx in nearly $8B deal

Health Angus Chen

STAT Plus: Nature Medicine to investigate study that found cancer treatment is better in morning

Biotech Matthew Herper and Angus Chen

STAT Plus: Key study of Grail’s cancer detection test fails in setback for company

Health Annalisa Merelli

Should semen analysis become the Pap smear for men? Some men’s health experts say yes

Business Angus Chen

STAT Plus: As oncologists ponder how to integrate AI-powered cancer tools, products are hitting the market

Health Associated Press

Bayer agrees to $7.25 billion proposed settlement over thousands of Roundup cancer lawsuits

Hospitals Jessica Bartlett — Boston Globe

STAT Plus: Breakup between Brigham and Dana-Farber is getting messier fast

First Opinion Gilberto Lopes

A Greek myth explains the biggest challenge facing oncologists like me

Health Andrew Joseph

Lung cancer in ‘never-smokers’ draws new focus — and questions

Politics Rachana Pradhan | KFF Health News

National Cancer Institute studying ivermectin’s ‘ability to kill cancer cells,’ alarming career scientists

Health tech Katie Palmer

STAT Plus: Hims, other telehealth platforms push multi-cancer detection tests before evidence of benefit

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: Dispute between Corcept Therapeutics, FDA runs deep

Health Angus Chen

Do mornings make cancer immunotherapy more effective? Study: Maybe

Letters to the editor Torie Bosch

STAT readers on shared decision-making, prostate cancer screening, and more

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: ImmunityBio’s Soon-Shiong mischaracterized talks with FDA over cancer drug, sources say

Opinions+ Barbara Levy and Badrinath Konety

STAT Plus: Medicare may start covering multi-cancer early detection tests. It should proceed with caution